Linovio-M
Twin Power for Total Control
COMPOSITION
Linagliptin 2.5mg + Metformin HCL 500/1000mg
INDICATION
- Type 2 Diabetes Mellitus (T2DM) Management
- DPP-4 Inhibitor
- Blood Sugar Control
- Treatment Limitations
- Prescription-Based Usage
Description
Linovio-M
- Substantial improvement in glycaemic control without weight gain or increased risk of hypoglycaemia Dinseres Chess Metab. 2011 Jari5-74
- The complementary mechanisms of Linagliptin and Metformin result in synergistic glucose-lowering effects. Cin Wwe saghts Clb 2015,8
- Significant improvements in HbA1c and fasting plasma glucose (FPG) compared with metformin alone.
- Statistically significant A1c reductions in a fixed-dose combination.
